CA2926641A1 - Novel peptide compositions - Google Patents
Novel peptide compositions Download PDFInfo
- Publication number
- CA2926641A1 CA2926641A1 CA2926641A CA2926641A CA2926641A1 CA 2926641 A1 CA2926641 A1 CA 2926641A1 CA 2926641 A CA2926641 A CA 2926641A CA 2926641 A CA2926641 A CA 2926641A CA 2926641 A1 CA2926641 A1 CA 2926641A1
- Authority
- CA
- Canada
- Prior art keywords
- peptide
- weight
- amino acid
- pharmaceutical composition
- peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361890056P | 2013-10-11 | 2013-10-11 | |
| US61/890,056 | 2013-10-11 | ||
| US201461940095P | 2014-02-14 | 2014-02-14 | |
| US61/940,095 | 2014-02-14 | ||
| PCT/US2014/058646 WO2015054006A2 (en) | 2013-10-11 | 2014-10-01 | Novel peptide compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2926641A1 true CA2926641A1 (en) | 2015-04-16 |
Family
ID=52813728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2926641A Abandoned CA2926641A1 (en) | 2013-10-11 | 2014-10-01 | Novel peptide compositions |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP3054967A4 (enExample) |
| JP (1) | JP2017501967A (enExample) |
| KR (1) | KR20160065969A (enExample) |
| CN (1) | CN105828831A (enExample) |
| AU (1) | AU2014332346B2 (enExample) |
| BR (1) | BR112016007816A2 (enExample) |
| CA (1) | CA2926641A1 (enExample) |
| CL (1) | CL2016000836A1 (enExample) |
| IL (1) | IL244956B (enExample) |
| MX (1) | MX2016004660A (enExample) |
| RU (1) | RU2016112931A (enExample) |
| SG (1) | SG11201602661PA (enExample) |
| WO (1) | WO2015054006A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6863362B2 (ja) * | 2016-03-03 | 2021-04-21 | 不二製油株式会社 | 神経栄養因子の脳内分泌促進するための食品添加用組成物 |
| EA201991699A1 (ru) * | 2017-02-16 | 2020-01-21 | Кареджен Ко., Лтд. | Конъюгат салициловой кислоты и пептида |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4244946A (en) | 1979-06-11 | 1981-01-13 | The Salk Institute For Biological Studies | Water-soluble peptides affecting gonadal function |
| US4305872A (en) | 1979-10-19 | 1981-12-15 | Kenneth Wingrove | Polypeptide derivatives |
| US4316891A (en) | 1980-06-14 | 1982-02-23 | The Salk Institute For Biological Studies | Extended N-terminal somatostatin |
| DE69738326T2 (de) | 1996-07-12 | 2008-07-03 | Mcgill University, Montreal | Verbindungen und verfahren zur regulierung der zellanlagerung |
| WO2001053331A2 (en) | 2000-01-24 | 2001-07-26 | Adherex Technologies, Inc. | Peptidomimetic modulators of cell adhesion |
| AU2002335657A1 (en) | 2001-08-24 | 2003-03-10 | Neuronz Biosciences, Inc. | Neural regeneration peptide and methods for their use in treatment of brain damage |
| US7563862B2 (en) | 2001-08-24 | 2009-07-21 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and methods for their use in treatment of brain damage |
| AU2003293807A1 (en) * | 2002-12-24 | 2004-07-22 | Algonomics N.V. | Mhc class i restricted t-cell stimulating peptides from hepatitis b virus |
| EP1685151A4 (en) * | 2003-10-31 | 2009-04-22 | Neuren Pharmaceuticals Ltd | PEPTIDES FOR THE REGENERATION OF NERVES AND METHOD FOR THEIR APPLICATION IN THE TREATMENT OF BRAIN DAMAGES |
| WO2007011595A2 (en) | 2005-07-15 | 2007-01-25 | Neuren Pharmaceuticals Limited | Neural regeneration peptides and antioxidants protect neurons from degeneration |
| WO2012006598A2 (en) * | 2010-07-09 | 2012-01-12 | Dana-Farber Cancer Institute, Inc. | Stabilized insulinotropic peptides and methods of use |
| KR20140140546A (ko) * | 2012-02-10 | 2014-12-09 | 타릭스 파마슈티컬스 엘티디. | 말초 혈관 질환의 치료를 위한 조성물 및 방법 |
-
2014
- 2014-10-01 BR BR112016007816A patent/BR112016007816A2/pt not_active Application Discontinuation
- 2014-10-01 CN CN201480066852.9A patent/CN105828831A/zh active Pending
- 2014-10-01 AU AU2014332346A patent/AU2014332346B2/en not_active Ceased
- 2014-10-01 MX MX2016004660A patent/MX2016004660A/es unknown
- 2014-10-01 EP EP14852391.3A patent/EP3054967A4/en not_active Withdrawn
- 2014-10-01 SG SG11201602661PA patent/SG11201602661PA/en unknown
- 2014-10-01 JP JP2016521985A patent/JP2017501967A/ja active Pending
- 2014-10-01 CA CA2926641A patent/CA2926641A1/en not_active Abandoned
- 2014-10-01 RU RU2016112931A patent/RU2016112931A/ru not_active Application Discontinuation
- 2014-10-01 WO PCT/US2014/058646 patent/WO2015054006A2/en not_active Ceased
- 2014-10-01 KR KR1020167011913A patent/KR20160065969A/ko not_active Withdrawn
-
2016
- 2016-04-06 IL IL24495616A patent/IL244956B/en not_active IP Right Cessation
- 2016-04-11 CL CL2016000836A patent/CL2016000836A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105828831A (zh) | 2016-08-03 |
| IL244956B (en) | 2019-10-31 |
| SG11201602661PA (en) | 2016-05-30 |
| KR20160065969A (ko) | 2016-06-09 |
| EP3054967A4 (en) | 2017-04-19 |
| BR112016007816A2 (pt) | 2017-12-05 |
| WO2015054006A2 (en) | 2015-04-16 |
| AU2014332346B2 (en) | 2019-01-24 |
| MX2016004660A (es) | 2016-11-14 |
| EP3054967A2 (en) | 2016-08-17 |
| WO2015054006A3 (en) | 2015-06-04 |
| JP2017501967A (ja) | 2017-01-19 |
| AU2014332346A1 (en) | 2016-05-05 |
| IL244956A0 (en) | 2016-05-31 |
| RU2016112931A (ru) | 2017-11-16 |
| CL2016000836A1 (es) | 2016-09-16 |
| RU2016112931A3 (enExample) | 2018-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018205186B2 (en) | Angiotensin in treating brain conditions | |
| US10960045B2 (en) | Methods and compositions for the treatment of epidermolysis bullosa | |
| US20180050079A1 (en) | Angiotensin peptides in treating marfan syndrome and related disorders | |
| CA2909002A1 (en) | Angiotensins in muscular dystrophy | |
| CA2940751C (en) | Uses of an angiotensin (1-7) peptide for the delayed treatment of stroke | |
| AU2014332346B2 (en) | Novel peptide compositions | |
| US20160296591A1 (en) | Compositions and methods for treatment of bdnf-related conditions | |
| US9133241B2 (en) | Peptide compositions | |
| WO2015057403A2 (en) | Compositions and methods for treatment of inflammatory bowel disease | |
| WO2025122594A1 (en) | Improved methods and compositions for the treatment of pemphigus or pemphigoid disease | |
| WO2016010844A1 (en) | Methods and compositions for the treatment of stroke |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190919 |
|
| FZDE | Discontinued |
Effective date: 20211206 |